272 related articles for article (PubMed ID: 17875983)
1. Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
Colombo A; Chieffo A
Circulation; 2007 Sep; 116(12):1424-32. PubMed ID: 17875983
[No Abstract] [Full Text] [Related]
2. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
3. Current drug-eluting stents in complex patients and lesions.
Elezi S; Dibra A; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
[TBL] [Abstract][Full Text] [Related]
4. Could Paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?
Brilakis ES; Banerjee S
Am J Cardiol; 2010 Nov; 106(9):1367-8. PubMed ID: 21029842
[No Abstract] [Full Text] [Related]
5. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
7. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
Klein LW
J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659
[TBL] [Abstract][Full Text] [Related]
8. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?
Vermeersch P; Agostoni P
J Interv Cardiol; 2005 Dec; 18(6):467-73. PubMed ID: 16336427
[TBL] [Abstract][Full Text] [Related]
9. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
10. Very late [corrected] thrombosis of a sirolimus-eluting stent.
Henderson D; Gunalingam B
Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease.
Guyton RA
Ann Thorac Surg; 2006 Jun; 81(6):1949-57. PubMed ID: 16731112
[TBL] [Abstract][Full Text] [Related]
12. Saphenous vein graft disease.
Peykar S; Angiolillo DJ; Bass TA; Costa MA
Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent in saphenous vein graft lesions.
Kornowski R
Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
[No Abstract] [Full Text] [Related]
14. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
16. Left main coronary artery stenting: crossing the Rubicon.
Alfonso F
J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
[No Abstract] [Full Text] [Related]
17. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
19. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
Yarkoni A; Brodsky A; Sabapathy R; Pershad A
Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
[TBL] [Abstract][Full Text] [Related]
20. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
Gil RJ
Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
